Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Refractive Surgery and Optive Compatibility Study

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00469157
First received: May 2, 2007
Last updated: April 16, 2008
Last verified: April 2008

May 2, 2007
April 16, 2008
May 2007
April 2008   (final data collection date for primary outcome measure)
Assess compatibility [ Time Frame: 8 months ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00469157 on ClinicalTrials.gov Archive Site
comfort [ Time Frame: 8 months ] [ Designated as safety issue: No ]
Not Provided
Not Provided
Not Provided
 
Refractive Surgery and Optive Compatibility Study
Refractive Surgery and Optive Compatibility Study

To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.

Not Provided
Interventional
Phase 4
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Dry Eye Syndromes
Drug: Optive
Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery
1.
Intervention: Drug: Optive
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
92
April 2008
April 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Men and women 18 and over
  • Patients undergoing refractive surgery

Exclusion Criteria:

  • Concurrent ocular conditions or pathology that could affect patient's ability to complete study
  • Concurrent use of topical medications other than study medications
  • Use of systemic medications with ocular drying sequelae:

    • Antihistamines
    • Decongestants
    • Antispasmotics
    • Antidepressants
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00469157
5303
Not Provided
Loren Rude, OD, TLC
Innovative Medical
Not Provided
Principal Investigator: Loren Rude, OD TLC
Innovative Medical
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP